Funding of $12.2 million has been allocated to critical research projects in Otago, aiming to close the gap between Māori and non-Māori cancer deaths. One of the seven grants awarded in the latest round of HRC Projects and Programmes funding will support a team led by Professor Sue Crengle from Otago’s Ngāi Tahu Māori Health Research Unit.
The team plans to design a lung cancer screening program tailored to those most in need, particularly focusing on Māori women, for whom lung cancer is the leading cause of death in New Zealand. The funding will enable in-depth research into utilizing a biomarker for enhanced lung cancer risk prediction and the incorporation of artificial intelligence in the screening process.
Professor Crengle highlighted the significance of improving risk prediction accuracy through the biomarker, which reflects tobacco exposure and could enhance screening efficiency. The team will also explore community and health professional perspectives on implementing AI technology in scan readings, alongside radiologists, while comparing Māori and European CT scans to identify potential biases in AI models.
Dr. Karen Bartholomew of Health New Zealand emphasized the program’s role in shaping a national lung cancer screening initiative, positioning New Zealand as a pioneer in equitable screening strategies.
These grants represent a broader spectrum of research initiatives, including investigations into the mental health impacts of climate change, falls prevention pathways for older adults, hormonal influences on maternal behavior, and rangatahi Māori experiences with smoking and vaping.
The allocated funding aims to drive innovative research addressing critical health issues and promoting equity in healthcare outcomes across New Zealand. The collaboration of established researchers and emerging talent underscores Otago’s commitment to advancing impactful research for the benefit of the community.
